Doseology USA Inc. Secures Key Manufacturing Partnership
KELOWNA, British Columbia — Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70), an innovative company specializing in precision-formulated oral stimulants, has made significant strides by entering into a manufacturing agreement through its subsidiary, Doseology USA Inc. This partnership with a leading North American production firm marks an important step forward in optimally positioning the company for market entry.
The Significance of This Collaboration
This new agreement is more than just a simple partnership; it signals Doseology's transition from research and development into the commercial landscape, setting the stage for introducing their advanced oral stimulant pouches to the market.
Insights from Leadership
Tim Corkum, President & COO of Doseology, highlights the importance of this agreement: "This is a defining moment as it enables Doseology to move from R&D to commercial deployment. Through Doseology USA Inc., we’ve secured an American partner that delivers the scale, quality, and integrity we require as we prepare to enter the oral stimulant pouch market.”
Thorough Diligence Process Conducted
Doseology’s leadership team undertook an extensive examination of various North American facilities through operational assessments and compliance audits. This rigorous process led to the selection of a manufacturing partner celebrated for its:
- Certified & Compliant Production: The partner operates an FDA-registered, GMP-certified, and ISO 9001:2015-approved facility, ensuring the highest product quality and safety standards.
- Turnkey Manufacturing Expertise: From formulation and ingredient sourcing to blending, packaging, and logistics, the partner offers complete manufacturing solutions.
- Oral Pouch Specialization: They provide precision control over nicotine, caffeine, and nootropic pouch formats, tailored to specific dosage, moisture, and flavor requirements.
- Rigorous Quality & Regulatory Systems: The manufacturing process includes built-in quality assurance and traceability measures aligned with FDA and ISO standards.
- Scalable, Low-Risk Partnership Model: The partner provides flexible production volumes to accommodate pilot runs, regional launches, and large-scale commercial production.
Commitment to Integrity and Quality
Corkum elaborates on their diligence process, stressing that they sought a manufacturing partnership that embodies the core values of integrity, quality, and accountability. This alignment ensures that Doseology’s offerings are built on a foundation of trusted North American craftsmanship.
A Milestone for Shareholders
The conclusion of this manufacturing agreement signifies a turning point in Doseology’s growth trajectory and commercial strategy, indicating they have the operational framework necessary to advance significantly in the oral stimulant pouch market.
Looking Ahead with Confidence
Expressing optimism, Corkum remarked, "This step validates our readiness to scale. We’ve secured the right partner, the right structure, and the right systems to move confidently. For our shareholders, this milestone indicates a reliable pathway to value creation.”
Building Towards Future Success
With leadership experienced in regulated industries such as Big Tobacco, CPG, and Nutraceuticals, Doseology continues to establish a robust North American infrastructure dedicated to innovation and compliance. The formation of Doseology USA Inc. reinforces the company’s commitment to American manufacturing integrity and sustainable growth.
About Doseology Sciences Inc. (CSE: MOOD | PINK: DOSEF | FSE: VU70), is a pioneering biotech firm focused on engineering advanced, precision-formulated oral stimulants aimed at enhancing energy, focus, and cognitive performance. The company is at the forefront of next-generation performance solutions through rigorous research and innovative delivery technologies.
Media Contact:
Chris Jackson
Email: hello@doseology.com
Phone: 604.908.3095
Frequently Asked Questions
What is the significance of Doseology USA Inc.'s new manufacturing agreement?
The agreement signifies Doseology's shift from R&D to commercial deployment, establishing the necessary infrastructure for market entry.
Who is Doseology collaborating with for manufacturing?
Doseology has partnered with a reputable North American production company known for its certified facilities and comprehensive manufacturing services.
What products will Doseology focus on?
Doseology specializes in precision-formulated oral stimulants, particularly oral stimulant pouches containing various ingredients like nicotine and caffeine.
How does this partnership benefit Doseology's shareholders?
This strategic move demonstrates Doseology's preparedness for market engagement, potentially leading to increased value creation for shareholders.
What future plans does Doseology have?
Doseology aims to continue building its North American infrastructure to support innovation while ensuring compliance and performance as they scale their operations.
